Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Bizzarri, N; Razumova, Z; Selcuk, I; Taumberger, N; Nikolova, T; Fotopoulou, C; Van der Steen-Banasik, E; Ferrero, A; Zalewski, K.
Report from the 21st meeting of the European Society of Gynaecological Oncology (ESGO 2019).
Int J Gynecol Cancer. 2020; 30(4):441-447
Doi: 10.1136/ijgc-2020-001226
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Taumberger Nadja
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This is a report from the 21st Meeting of the European Society of Gynaecological Oncology (ESGO 2019) held in Athens, Greece, November 2-5, 2019. The conference offered state of the art educational sessions, and oral and poster abstract presentations. The general sessions throughout the meeting focused not only on prevention, screening, diagnosis, treatment, and translational research but also on emerging trends. Current innovations in gynecological cancers were also discussed. The new rare tumor guidelines project, a joint initiative with the ESGO-Gynecologic Cancer InterGroup, was officially presented for the first time. Moreover, other developments achieved with other societies, such as the European Society for Medical Oncology for ovarian cancer, the European Federation for Colposcopy for cervical cancer prevention and screening, and the European Society for Pediatric Oncology for gynecologic cancers in adolescents, were presented. Here we highlight the key results of the latest gynecological cancer trials that were presented for the first time at ESGO 2019 and added great value to this prestigious scientific congress. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.
- Find related publications in this database (Keywords)
- ovarian cancer
- cervical cancer
- vulvar and vaginal cancer
- radiation oncology
- surgical oncology